PGNY 15.27 (-3.05%)
US74340E1038• Healthcare Providers & Services• Health Information Services
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PGNY

Progyny (PGNY) Competitor Comparison

We are evaluating the key criteria listed to compare Progyny (PGNY) against its competitors in the Health Information Services industry.

Market Capitalization

7 / 35

Gross Profits

18 / 31

Total Revenue

12 / 33

EBITDA

13 / 33

Free Cashflow

8 / 34

Quick Ratio

13 / 34

Earnings per Share

6 / 33

Dividend yield

0 / 3

Total Cash

12 / 34

Performance 3 years

20 / 35

Performance 5 years

19 / 35

Performance 10 years

9 / 35

Linearity 3 years

14 / 35

Linearity 5 years

14 / 35

Linearity 10 years

2 / 35

Total Rank

22 / 35

Dividend Rank

17 / 35

Valuation Rank

28 / 35

Piotroski Rank

2 / 35

Muliplier Rank

27 / 35

Linearity 10 years - PGNY ranking 2 / 35

These are the competitors of Progyny in the industry Health Information Services ranked by linearity 10 years
1. Agiliti AGTI
513.03
2. Progyny PGNY
50.57
3. Allscripts Healthcare Solutions MDRX
25.17
4. NextGen Healthcare NXGN
21.98
5. CareCloud MTBC
19.39
6. Doximity DOCS
16.7
7. OptimizeRx OPRX
16.16
8. Tabula Rasa HealthCare TRHC
15.85
9. Phreesia PHR
12
10. Omnicell OMCL
10.24
11. 1Life Healthcare ONEM
9.78
12. Signify Health SGFY
8.8
13. Teladoc Health TDOC
8.2
14. Evolent Health EVH
6.95
15. Premier Inc PINC
6.4
16. 10x Genomics TXG
5.06
17. Privia Health Group PRVA
4.8
18. HeartBeam BEAT
3.65
19. Covetrus CVET
3.16
20. Augmedix AUGX
2.73
21. Accolade ACCD
2.64
22. icad ICAD
2.31
23. CareMax CMAX
2.13
24. SomaLogic SLGC
2.03
25. Sophia Genetics SOPH
2.01
26. Change Healthcare CHNG
1.95
27. GoodRx Holdings GDRX
1.86
28. Forian FORA
1.75
29. ZHONGCHAO ZCMD
1.69
30. Definitive Healthcare DH
1.68
31. Simulations Plus SLP
1.61
32. NantHealth NH
1.36
33. iCoreConnect ICCT
1.31
34. Veeva Systems VEEV
0.55
35. Healthcare Triangle HQY
0.47
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.